Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00166543
Status:
COMPLETED
Last Update Posted:
2015-08-18
First Post:
2005-09-12
Brief Title:
Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer
Sponsor:
SRI International
Organization:
SRI International
Organization Data
Organization:
SRI International
Class:
INDUSTRY
Study ID:
2216-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SRI International
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Taiho Pharmaceutical Co Ltd | INDUSTRY |